Dr Link is a CSIC researcher with more than 20 years of experience in basic and translational biomedical research reflected in 77 publications, 35 as senior author, with 4354 citations, three patents, numerous invited key note and plenary presentations at international conferences, funded research projects, entrepreneurship (Cofounder and CSO of a biotech company) and an extensive network of contacts and collaborations (member of three COST actions). Dr Link very recently joined Alberto Sols Biomedical Research Institute (IIB, CSIC-UAM) to build a research group focussed on drug resistance mechanisms in cancer. He obtained his PhD degree from the University of Hamburg, followed by a postdoc at CNB (Madrid), before joining the pharma company EleGene AG (Germany) as a senior scientist. In 2001, he moved to Madrid joining the newly-founded CNIO where he was promoted to head the screening group in 2010. In 2012 he accepted a position as assistant professor at the Department of Biomedical Sciences and Medicine (DCBM, University of Algarve, Faro, Portugal) where he was head of the Department of Oncobiology (CBMR, University of Algarve, Faro, Portugal) and director of the Masters program on Molecular mechanisms of cancer.